Baritava 4mg by Hikma Pharmaceuticals contains Baricitinib 4 mg in each film-coated tablet. Baricitinib is a selective and reversible inhibitor of Janus kinases (JAK1 and JAK2), part of an important signalling pathway for several inflammatory and immune-mediated conditions.
Each pack contains 28 film-coated tablets — typically a 4-week course at the recommended once-daily dose, but the dosing schedule and duration must be set by your prescribing physician based on the indication and your individual response.
Important: This is a prescription-only medicine. Do not start, stop, or change the dose without consulting your doctor. Tell your physician about any other medicines you are taking, any infections (active or recent), and any history of blood clots, heart disease, or cancer before starting therapy. Routine blood tests are usually required during treatment.
Tdawi sells Baritava as supplied by Hikma Egypt. Always read the patient leaflet inside the pack before use. Keep out of reach of children.
| Brand | Hikma |
|---|
Please complete your information below to login.
Sign In
Create New Account